✦ LIBER ✦

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer

✍ Scribed by Zhang, X.-T.

Book ID: 118045382
Publisher: Oxford University Press
Year: 2005
Tongue: English
Weight: 301 KB
Volume: 16
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdi340

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

EGFR mutations and HER2/3 protein expres

EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib

✍ Jian Ming Xu; Yu Han; Hai Qing Duan; E. Mei Gao; Yang Zhang; Xiao Qing Liu; Jing 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 521 KB

Polymorphisms of EGFR predict clinical o

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

Activity of ZD1839 (Gefitinib, Iressa™)

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

EGFR / HER2 / HER3 expression in tumour

EGFR / HER2 / HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-small cell lung cancer

✍ Jianming Xu; Emei Gao; Yu Han; Yang Zhang; Suxia Li; Xiaoqing Liu; Zhiqiang Li; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 282 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB